Skip to main content
Top
Published in: Digestive Diseases and Sciences 11/2020

01-11-2020 | Care | Original Article

Clinical Ontologies Improve Case Finding of Primary Biliary Cholangitis in UK Primary and Secondary Care

Authors: Marinos Pericleous, Claire Kelly, Joseph A. Odin, Yiannis Kallis, Chris McGee, Julian Sherlock, Ivelina Yonova, Simon de Lusignan, Aftab Ala

Published in: Digestive Diseases and Sciences | Issue 11/2020

Login to get access

Abstract

Introduction

PBC registries in the UK focus on data from secondary care without clear coordinated contribution from primary care. The Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) receives data from > 500 primary care practices (PCPs). Notably, the Lancet commissioning group is extracting data from the RCGP RSC database to shape UK policy on liver disease.

Aims

To create a novel ontology to facilitate PBC case finding from primary care provider (PCP) records.

Methods

RCGP RSC data were collected from participating PCPs in the county of Surrey, UK. PBC diagnostic criteria of the AASLD and EASL guidelines were used to develop 725 data codes to facilitate patient record searches. A scoring system built into the ontology allowed categorization of cases as PBC definite, PBC probable, and PBC unlikely.

Results

A total of 218,099 records were searched from participating PCPs. Of these, there were 58 PBC definite, 2317 PBC probable, and 215,724 PBC unlikely patients. There were 32 PBC definite patients who did not match to our regional PBC database and were henceforth included as new-found cases. Two of these cases were not labeled as PBC by the PCP. From the PBC unlikely group, 7/215,724 (0.003%) patients were labeled as PBC in secondary care records; however, none of them were coded as having PBC by their PCPs.

Conclusions

Utilization of the UK National RCGP RSC database supported by novel ontology score has successfully helped us identify (i) new cases of PBC not known to local/regional secondary care providers and (ii) de novo PBC cases. There are many PBC probable cases whose data merit further careful evaluation.
Appendix
Available only for authorised users
Literature
7.
go back to reference de Lusignan S. Codes, classifications, terminologies and nomenclatures: definition, development and application in practice. Inform Prim Care. 2005;13:65–70.PubMed de Lusignan S. Codes, classifications, terminologies and nomenclatures: definition, development and application in practice. Inform Prim Care. 2005;13:65–70.PubMed
10.
go back to reference Hu FL, Cheng H, Zhang XZ, et al. Jinghuaweikang capsules combined with triple therapy in the treatment of Helicobacter pylori associated gastritis and duodenal ulcer and analysis of antibiotic resistance: a multicenter, randomized, controlled, clinical study. Zhonghua Yi Xue Za Zhi. 2012;92:679–684.PubMed Hu FL, Cheng H, Zhang XZ, et al. Jinghuaweikang capsules combined with triple therapy in the treatment of Helicobacter pylori associated gastritis and duodenal ulcer and analysis of antibiotic resistance: a multicenter, randomized, controlled, clinical study. Zhonghua Yi Xue Za Zhi. 2012;92:679–684.PubMed
38.
go back to reference Donnan PT, McLernon D, Dillon JF, Ryder S, Roderick P, Sullivan F et al. Development of a decision support tool for primary care management of patients with abnormal liver function tests without clinically apparent liver disease: a record-linkage population cohort study and decision analysis (ALFIE). Health Technol Assess. 2009;13(25):iii-iv, ix-xi, 1-134. https://doi.org/10.3310/hta13250. Donnan PT, McLernon D, Dillon JF, Ryder S, Roderick P, Sullivan F et al. Development of a decision support tool for primary care management of patients with abnormal liver function tests without clinically apparent liver disease: a record-linkage population cohort study and decision analysis (ALFIE). Health Technol Assess. 2009;13(25):iii-iv, ix-xi, 1-134. https://​doi.​org/​10.​3310/​hta13250.
44.
go back to reference Pericleous M, Kelly C, De Lusignan S, Ala A, editors. Developing a novel real-world south east England registry for primary biliary cholangitis (PBC) allowing data-linkage from primary to secondary care-preliminary findings from a UK national institute for health research (NIHR) portfolio study. Hepatology; 2018: Wiley 111 RIVER ST, HOBOKEN 07030-5774, NJ USA. Pericleous M, Kelly C, De Lusignan S, Ala A, editors. Developing a novel real-world south east England registry for primary biliary cholangitis (PBC) allowing data-linkage from primary to secondary care-preliminary findings from a UK national institute for health research (NIHR) portfolio study. Hepatology; 2018: Wiley 111 RIVER ST, HOBOKEN 07030-5774, NJ USA.
45.
go back to reference Steinke DT, Weston TL, Morris AD, MacDonald TM, Dillon JF. The epidemiology of liver disease in Tayside database: a population-based record-linkage study. J Biomed Inform. 2002;35:186–193.CrossRef Steinke DT, Weston TL, Morris AD, MacDonald TM, Dillon JF. The epidemiology of liver disease in Tayside database: a population-based record-linkage study. J Biomed Inform. 2002;35:186–193.CrossRef
46.
go back to reference Sherwood P, Lyburn I, Brown S, Ryder S. How are abnormal results for liver function tests dealt with in primary care? Audit of yield and impact. BMJ. 2001;322:276–278.CrossRef Sherwood P, Lyburn I, Brown S, Ryder S. How are abnormal results for liver function tests dealt with in primary care? Audit of yield and impact. BMJ. 2001;322:276–278.CrossRef
49.
go back to reference Dyson J, Shirley M, Blain A, Hudson M, Rushton S, Jones D. Disease clustering in autoimmune liver diseases points towards environmental factors being important in their aetiology. J Hepatol. 2019;70:e11–e12.CrossRef Dyson J, Shirley M, Blain A, Hudson M, Rushton S, Jones D. Disease clustering in autoimmune liver diseases points towards environmental factors being important in their aetiology. J Hepatol. 2019;70:e11–e12.CrossRef
Metadata
Title
Clinical Ontologies Improve Case Finding of Primary Biliary Cholangitis in UK Primary and Secondary Care
Authors
Marinos Pericleous
Claire Kelly
Joseph A. Odin
Yiannis Kallis
Chris McGee
Julian Sherlock
Ivelina Yonova
Simon de Lusignan
Aftab Ala
Publication date
01-11-2020
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2020
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-06039-x

Other articles of this Issue 11/2020

Digestive Diseases and Sciences 11/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.